Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Xeris Biopharma Holdings, Inc. (XERS) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.45B and a free-cash-flow yield of 2.0%. Over the most recent reported fiscal year, revenue grew 43.7%.